Ohio Xarelto Lawyers

The Ohio Pharmaceutical Injury Attorneys at Clark, Perdue & List are investigating claims for personal injury and death arising from use of Xarelto.

Xarelto (“Rivaroxaban”) is one of the newest prescription anticoagulants on the market. This dangerous drug, manufactured by Bayer and marketed in the United Stated by Janssen Pharmaceuticals, a Johnson & Johnson subsidiary, is already nearing “blockbuster” status with projected sales exceeding $1 billion by the end of 2014. Since its FDA approval in 2011, numerous cases of serious bleeding events, cerebral hemorrhages, strokes, blood clots and heart attacks have been reported. In 2012 – the second year Xarelto was on the market – the U.S. FDA reported 151 deaths and 2,081 serious complications associated with Xarelto. In just the first quarter of 2013, nearly 700 adverse complications were reported.

All blood thinning medications create a risk of excess bleeding. But learn more about why the bleeding risk with Xarelto can be more dangerous than with Warfarin.

Many medical professionals have expressed concern about Xarelto’s safety. Like Pradaxa, another blood thinner, there is no antidote for uncontrolled bleeding caused by Xarelto.

Xarelto lawsuit, involving hundreds of consumers, is ongoing.

 

Contact the Ohio Xarelto lawyers

If you or a loved one has suffered serious side effects after taking Xarelto, contact the Ohio Xarelto lawyers at Clark, Perdue & List. Our pharmaceutical injury attorneys have successfully represented hundreds of people who have suffered injury or death as a result of a dangerous drug or defective medical device.

BLOG POSTS ABOUT XARELTO

Dangerous drugs: Xarelto lawsuits mount

Xarelto, one of the dangerous drugs currently on the market, has been blamed for numerous injuries in users as a result of excessive bleeding. Injuries include excessive gastrointestinal bleeding, brain ...
Read More

Dangerous drugs alert: Xarelto linked to higher risk of GI bleeds

Dangerous drugs alert: A recently published study indicates that patients who use the anticoagulant Xarelto are at a greatly increased risk of experiencing gastrointestinal bleeding.The new study was published in ...
Read More

Dangerous drugs update: Xarelto MDL Science Day Set

Dangerous drugs update: U.S. District Judge Eldon Fallon, who is presiding over the Xarelto multi district litigation ("MDL"), has scheduled a Xarelto "science day" on June 14, 2015. The purpose ...
Read More

Dangerous drugs: Xarelto makers fight consolidation of suits

Dangerous drugs update: Johnson & Johnson and Bayer, the makers of anticoagulant Xarelto, are opposing the consolidation of lawsuits that have been filed over adverse side effects of the drug ...
Read More

Xarelto dangerous drug claims grow; additional FDA approval sought

Even as Xarelto dangerous drugs claims are being filed across the United States, Bayer and Johnson & Johnson are continuing efforts to secure additional approved uses for the drug from ...
Read More